Experimental pill sends a THIRD of patients with leukemia into complete remission in early trial

Researchers in Boston, Massachusetts, said the results of the trial were 'very encouraging'. They could seek FDA approval for the treatment by the end of this year.

Source: the Mail online | Health - March 24, 2023 Category: Consumer Health News Source Type: news